Louisiana State Employees Retirement System Decreases Stock Position in U.S. Physical Therapy, Inc. (NYSE:USPH)

Louisiana State Employees Retirement System cut its position in U.S. Physical Therapy, Inc. (NYSE:USPH) by 3.9% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,300 shares of the company’s stock after selling 300 shares during the quarter. Louisiana State Employees Retirement System’s holdings in U.S. Physical Therapy were worth $618,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in the company. Silvercrest Asset Management Group LLC purchased a new position in U.S. Physical Therapy in the 1st quarter valued at approximately $8,158,000. Renaissance Technologies LLC grew its stake in U.S. Physical Therapy by 763.7% in the 2nd quarter. Renaissance Technologies LLC now owns 69,523 shares of the company’s stock valued at $6,425,000 after buying an additional 61,474 shares in the last quarter. Penn Davis Mcfarland Inc. purchased a new position in U.S. Physical Therapy in the 3rd quarter valued at approximately $2,552,000. Dimensional Fund Advisors LP grew its stake in U.S. Physical Therapy by 2.5% in the 2nd quarter. Dimensional Fund Advisors LP now owns 423,846 shares of the company’s stock valued at $39,173,000 after buying an additional 10,462 shares in the last quarter. Finally, Vanguard Group Inc. grew its stake in U.S. Physical Therapy by 1.0% in the 1st quarter. Vanguard Group Inc. now owns 1,072,602 shares of the company’s stock valued at $121,065,000 after buying an additional 10,175 shares in the last quarter.

U.S. Physical Therapy Stock Down 0.4 %

USPH opened at $82.50 on Wednesday. The company has a fifty day moving average price of $82.94 and a 200-day moving average price of $91.61. The firm has a market capitalization of $1.24 billion, a P/E ratio of 78.26, a price-to-earnings-growth ratio of 3.86 and a beta of 1.38. The company has a debt-to-equity ratio of 0.28, a current ratio of 1.88 and a quick ratio of 1.88. U.S. Physical Therapy, Inc. has a one year low of $76.18 and a one year high of $113.63.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings results on Tuesday, August 13th. The company reported $0.73 EPS for the quarter, missing analysts’ consensus estimates of $0.82 by ($0.09). U.S. Physical Therapy had a net margin of 4.06% and a return on equity of 8.18%. The firm had revenue of $167.19 million for the quarter, compared to analysts’ expectations of $163.34 million. During the same quarter last year, the firm earned $0.76 earnings per share. The firm’s revenue for the quarter was up 10.4% on a year-over-year basis. Equities research analysts expect that U.S. Physical Therapy, Inc. will post 2.58 earnings per share for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, September 13th. Investors of record on Friday, August 23rd were given a $0.44 dividend. The ex-dividend date of this dividend was Friday, August 23rd. This represents a $1.76 annualized dividend and a yield of 2.13%. U.S. Physical Therapy’s dividend payout ratio (DPR) is presently 166.04%.

Analysts Set New Price Targets

USPH has been the subject of a number of recent research reports. Bank of America reiterated a “neutral” rating and issued a $90.00 price objective (down from $114.00) on shares of U.S. Physical Therapy in a research note on Monday, October 7th. StockNews.com upgraded shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Wednesday, August 21st. Finally, Barrington Research restated an “outperform” rating and set a $108.00 price target on shares of U.S. Physical Therapy in a research report on Wednesday, October 9th.

Insider Buying and Selling

In related news, COO Graham D. Reeve sold 1,724 shares of the company’s stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $82.50, for a total value of $142,230.00. Following the completion of the transaction, the chief operating officer now directly owns 7,038 shares in the company, valued at approximately $580,635. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other U.S. Physical Therapy news, Director Kathleen A. Gilmartin purchased 2,000 shares of the stock in a transaction on Tuesday, September 3rd. The stock was acquired at an average cost of $86.09 per share, with a total value of $172,180.00. Following the completion of the purchase, the director now directly owns 18,904 shares of the company’s stock, valued at approximately $1,627,445.36. This trade represents a 0.00 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, COO Graham D. Reeve sold 1,724 shares of the business’s stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $82.50, for a total transaction of $142,230.00. Following the completion of the sale, the chief operating officer now directly owns 7,038 shares of the company’s stock, valued at $580,635. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.70% of the stock is owned by company insiders.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.